Concord Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE858L01010
  • NSEID:
  • BSEID: 538965
INR
71.00
0.36 (0.51%)
BSENSE

Apr 02

BSE+NSE Vol: 2.36 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 605306,
    "name": "Concord Drugs",
    "stock_name": "Concord Drugs",
    "full_name": "Concord Drugs Ltd",
    "name_url": "stocks-analysis/concord-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "71.00",
    "chg": 0.36,
    "chgp": "0.51%",
    "dir": 1,
    "prev_price": "70.64",
    "mcapval": "72.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 538965,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE858L01010",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "2.36 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/concord-drugs-605306-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 256,
    "sid": "605306",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/concord-drugs-605306"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2026",
      "details": "Closure for the purpose of consideration of Audited (standalone and Consolidated) Results for the quarter and Financial year ending 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Feb-2026",
      "details": "News Paper publication of Q3 results",
      "source": "BSE"
    },
    {
      "caption": "General Update",
      "datetime": "16-Feb-2026",
      "details": "General Update",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Closure of Trading Window

27-Mar-2026 | Source : BSE

Closure for the purpose of consideration of Audited (standalone and Consolidated) Results for the quarter and Financial year ending 31st March 2026.

Announcement under Regulation 30 (LODR)-Newspaper Publication

17-Feb-2026 | Source : BSE

News Paper publication of Q3 results

General Update

16-Feb-2026 | Source : BSE

General Update

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available